|
PRINT COMPANY INFORMATION
| Market Information: |
| Last Trade: |
567.50 |
| Last Update |
May 22, 2013 at 05:06PM |
| Change |
|
| |
|
| Open Price |
574.0 |
| Adjusted Open Price |
569.7 |
| Yesterday Close Price |
569.7 |
|
| |
| Close Price |
569.7 |
| |
|
| Day's Range |
567.5 - 574.0 |
| |
|
| Volume |
1050 |
| |
|
| Total Trade |
18 |
| |
|
| Market Cap in BDT* |
6862.862 (mn) |
|
| |
|
|
|
| Basic Information: |
|
|
|
| Authorized Capital in BDT* (mn) |
200.0 |
|
|
| Paid-up
Capital in BDT* (mn) |
120.0 |
52 Week's Range |
470 - 640 |
| |
|
|
|
| Face Value |
10.0 |
Market Lot |
50 |
| |
|
|
|
| Total no. of Securities |
12046449 |
Business Segment |
Pharmaceuticals & Chemicals |
|
VIEW CLOSE PRICE GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
VIEW TOTAL TRADES GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
| Last AGM Held: 23/04/2013 |
| Bonus Issue |
n/a |
| |
|
| Right Issue |
n/a |
| |
|
| Year End |
201212 |
| |
|
| Reserve & Surplus in BDT* (mn) |
1365.1 |
|
| Interim
Financial Performance: 2013 |
Particulars |
Unaudited
/ Audited |
| Q1(3 Months)
|
Q2(6 Months)
|
Q3(9 Months)
|
Q4 (12 Months)
|
|
201303 |
|
|
|
Turn Over in BDT* (mn)
|
2142 |
n/a |
n/a |
n/a |
Net Profit After Tax in BDT *(mn) (Continuing Operations)
|
196.53 |
n/a |
n/a |
n/a |
| Net
Profit After Tax in BDT *(mn)
(Including Extra-ordinary Income) |
0 |
n/a |
n/a |
n/a |
Basic EPS in BDT*
(Based on continuing operations) |
16.310 |
n/a |
n/a |
n/a |
Diluted EPS in BDT* (Based on continuing
operations) |
|
0.000 |
n/a |
n/a |
n/a |
Basic
EPS in BDT* (Including Extra-ordinary Income) |
0.000 |
n/a |
n/a |
n/a |
Diluted EPS in BDT* (Including Extra-ordinary Income) |
|
0.000 |
n/a |
n/a |
n/a |
|
Profit Status :
| |
Basic |
Diluted |
Current Price Earning Ratio (P/E)
(Based on Continuing operation)
|
8.73 |
|
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
|
* Note - Based on Annualized
EPS of 2013 (Q1)
Price Earning Ratio Based
on last Audited Financials:
Current Price Earning Ratio (P/E)
(Based on Continuing Operation)
|
28.13 |
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
* Note - Based on
audited EPS of 2012
| Year |
Basic
EPS |
Basic
EPS (restated) |
Net Asset Value Per Share |
Restated
Net Asset Value Per Share |
Net Profit After Tax (mn) |
| Based on |
Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
Continuing operations |
Including Extra-Ordinary
Income |
Continuing operations |
Including Extra-Ordinary
Income |
| 2000 |
5.31 |
n/a |
n/a |
n/a |
49.08 |
n/a |
63.95 |
n/a |
| 2001 |
5.34 |
n/a |
n/a |
n/a |
49.85 |
n/a |
64.35 |
n/a |
| 2002 |
6.00 |
n/a |
n/a |
n/a |
51.84 |
n/a |
72.25 |
n/a |
| 2003 |
7.21 |
n/a |
n/a |
n/a |
54.62 |
n/a |
86.82 |
n/a |
| 2004 |
15.23 |
n/a |
n/a |
n/a |
69.49 |
n/a |
183.52 |
n/a |
| 2005 |
4.05 |
n/a |
n/a |
n/a |
68.05 |
n/a |
48.85 |
n/a |
| 2006 |
-1.42 |
n/a |
n/a |
n/a |
63.62 |
n/a |
-17.12 |
n/a |
| 2007 |
3.74 |
n/a |
n/a |
n/a |
66.35 |
n/a |
45.05 |
n/a |
| 2008 |
11.87 |
n/a |
n/a |
n/a |
75.72 |
n/a |
142.95 |
n/a |
| 2009 |
26.88 |
n/a |
n/a |
n/a |
96.60 |
n/a |
323.79 |
n/a |
| 2010 |
34.05 |
n/a |
n/a |
n/a |
114.65 |
n/a |
410.18 |
n/a |
| 2011 |
23.42 |
n/a |
n/a |
n/a |
118.07 |
n/a |
282.07 |
- |
| 2012 |
20.25 |
n/a |
n/a |
n/a |
123.32 |
n/a |
243.97 |
n/a |
|
|
All figures in BDT (Bangladeshi Taka) |
| Financial Performance (Continue): |
| Year |
Year End P/E |
% Dividend |
% Dividend Yield |
| Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
| 2000 |
16.01 |
n/a |
35.00 |
4.12 |
| 2001 |
19.47 |
n/a |
37.50 |
3.61 |
| 2002 |
19.89 |
n/a |
40.00 |
3.35 |
| 2003 |
27.83 |
n/a |
40.00 |
1.99 |
| 2004 |
9.40 |
n/a |
50.00 |
3.49 |
| 2005 |
33.29 |
n/a |
30.00 |
2.22 |
| 2006 |
- |
n/a |
10.00 |
0.74 |
| 2007 |
51.60 |
n/a |
25.00 |
1.30 |
| 2008 |
27.81 |
n/a |
60.00 |
1.82 |
| 2009 |
26.98 |
n/a |
160.00 |
2.21 |
| 2010 |
33.17 |
n/a |
200.00 |
1.77 |
| 2011 |
28.37 |
n/a |
150.00 |
2.26 |
| 2012 |
28.15 |
n/a |
150.00 |
2.63 |
|
| Details of Financial Statement |
|
| Price Sensitive Information |
|
| Other Information of the Company: |
| Listing Year |
1976 |
| |
|
| Market Category |
A |
| |
|
| Electronic Share |
Y |
| |
|
| Share Percentage: |
| Sponsor/Director 81.98 |
Govt.0 |
Institute 14.32 |
Foreign 0 |
Public 3.7 |
|
| Remark |
TK 59,479,000 Revaluation Reserve has been added to Reserve & Surplus. |
|
| Address of the Company: |
| Address: |
House # 2A, Road # 138, Gulshan - 01, Dhaka - 1212 |
| |
|
| Contact Phone: |
9858870-75 |
| |
|
| Fax: |
88 - 02 - 8826628 |
| |
|
| E-mail: |
gsk.bangladesh-info@gsk.com |
| Web Address: |
http://www.gsk.com.bd
|
|
* BDT - Bangladeshi Taka

STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/
|